Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP800680.RABXhc08fCvGd3Iki5b7pYqRhU087E2hySmNoxtI8L05k130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800680.RABXhc08fCvGd3Iki5b7pYqRhU087E2hySmNoxtI8L05k130_provenance.
• NP445218.RAkzxT7cLOkpq7ZRAFOVbH1k9Lr7AZMB1Gh6uysfuwxEk130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP445218.RAkzxT7cLOkpq7ZRAFOVbH1k9Lr7AZMB1Gh6uysfuwxEk130_provenance.
• NP823906.RAr__RbjnVQNMwxkZ2zh6h6NSIsNjGMv2VILmQFyb204s130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823906.RAr__RbjnVQNMwxkZ2zh6h6NSIsNjGMv2VILmQFyb204s130_provenance.
• NP846207.RArFFaNJhdUCrvdRmPA6D6UWX_PP4MmFWi0AzfM6IB-Ac130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP846207.RArFFaNJhdUCrvdRmPA6D6UWX_PP4MmFWi0AzfM6IB-Ac130_provenance.
• NP444438.RAGbDNfjZnzaFdCaVDwu1GYlCPjPQGlFsw9GFkXXWsQbM130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP444438.RAGbDNfjZnzaFdCaVDwu1GYlCPjPQGlFsw9GFkXXWsQbM130_provenance.
• assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP787016.RA57JjuXGKKY0Iwi03HIQapHobUAKErF_wy23UDpKsG3A130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787016.RA57JjuXGKKY0Iwi03HIQapHobUAKErF_wy23UDpKsG3A130_provenance.
• NP362055.RATzpK5jJk2Eh_0guGGERlSFaY0uK5FzgpuHKJJZVoZRs130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP362055.RATzpK5jJk2Eh_0guGGERlSFaY0uK5FzgpuHKJJZVoZRs130_provenance.
• NP657220.RAFs2dlYI1vW3DBWFkvqFRxZck-9-x4k-a8UUCn8dUUJc130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657220.RAFs2dlYI1vW3DBWFkvqFRxZck-9-x4k-a8UUCn8dUUJc130_provenance.
• assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP738674.RAMA4uLMNNhSUsnP8efsVfeT6SWzizYxu2hh4GXGfXhb0130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738674.RAMA4uLMNNhSUsnP8efsVfeT6SWzizYxu2hh4GXGfXhb0130_provenance.
• NP923890.RAOxP1XNiAMh2l5IXCUoTDh8CM0-MP3-uE5ifWLEo0-Yg130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923890.RAOxP1XNiAMh2l5IXCUoTDh8CM0-MP3-uE5ifWLEo0-Yg130_provenance.
• NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637239.RAQ1TqAwg6WWPU1lAtRfKByYjHfT67b43pMvkPcqKGIv4130_provenance.
• NP710286.RAJE3e4EUkeilrqWn1uP4UCdmnQpSIRn57bCN4rdQoLAc130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710286.RAJE3e4EUkeilrqWn1uP4UCdmnQpSIRn57bCN4rdQoLAc130_provenance.
• NP274364.RAmrUmJNOa79AhLcQAxfxy5sGBXrJdDCxHc-xtgHAvuRk130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP274364.RAmrUmJNOa79AhLcQAxfxy5sGBXrJdDCxHc-xtgHAvuRk130_provenance.
• NP731106.RAkuqCr7p7XBs_iGd2MFDvD5rKEciDiLAq10q7vQVOJVg130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731106.RAkuqCr7p7XBs_iGd2MFDvD5rKEciDiLAq10q7vQVOJVg130_provenance.
• NP637237.RAv_WKpHC9eMUnL39egPGDlBogPrKyMBS9a5ubnCcHwJk130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637237.RAv_WKpHC9eMUnL39egPGDlBogPrKyMBS9a5ubnCcHwJk130_provenance.
• NP637238.RAvjsxBE-S6MalIiQfRuIwIHz5Ud5Y_xBa6YBUB6O1cig130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637238.RAvjsxBE-S6MalIiQfRuIwIHz5Ud5Y_xBa6YBUB6O1cig130_provenance.
• NP637240.RAjUaz5Fc8S582cjy6Ln_8WoLDuQT2qG5kM9UTK4jdy8A130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637240.RAjUaz5Fc8S582cjy6Ln_8WoLDuQT2qG5kM9UTK4jdy8A130_provenance.
• NP382274.RAx4S1u3pQ92EelGH5UTFnHoVXZ3MQC2SERlXEqm3EtLE130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382274.RAx4S1u3pQ92EelGH5UTFnHoVXZ3MQC2SERlXEqm3EtLE130_provenance.
• NP826059.RA3rZMlUpKx6_zYwrI8Xie5s8tbPr_HL-U5PTEsgpj6Wc130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826059.RA3rZMlUpKx6_zYwrI8Xie5s8tbPr_HL-U5PTEsgpj6Wc130_provenance.
• NP637241.RA3NWtlhcY1mOc19XAHsw7343-Jrc0sBfzY6JrVkdMBpY130_assertion description "[Our study demonstrates that (i) ErbB/HER ligands, including BTC and EREG, are expressed in most breast cancers; and (ii) TGFalpha, HB-EGF and NRG2 high expressions are related to the biological aggressiveness of the tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637241.RA3NWtlhcY1mOc19XAHsw7343-Jrc0sBfzY6JrVkdMBpY130_provenance.